Virtu Financial’s Gossamer Bio GOSS Stock Holding History

Virtu Financial’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$76K	Buy	463,708 +200,496	+76%	+$56K	﹤0.01%	1153
2026 Q1	$86K	Buy	+263,212	New	+$414K	﹤0.01%	1215
2025 Q2	–	Sell	-34,971	Closed	-$38K	–	1686
2025 Q1	$38K	Buy	+34,971	New	+$40.4K	﹤0.01%	1043
2024 Q2	–	Sell	-14,433	Closed	-$17K	–	1512
2024 Q1	$17K	Sell	14,433 -18,464	-56%	-$20.3K	﹤0.01%	1190
2023 Q4	$30K	Buy	+32,897	New	+$24.3K	﹤0.01%	1253
2022 Q4	–	Sell	-15,563	Closed	-$186K	–	1824
2022 Q3	$186K	Buy	+15,563	New	+$193K	0.02%	897
2021 Q1	–	Sell	-13,256	Closed	-$128K	–	1770
2020 Q4	$128K	Buy	+13,256	New	+$131K	0.01%	993
2020 Q3	–	Sell	-13,637	Closed	-$177K	–	1245
2020 Q2	$177K	Buy	+13,637	New	+$172K	0.02%	749

Other funds holding GOSS

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

DIG

DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

Virtu Financial's GOSS Position: Q2 2026 in Review

Virtu Financial increased its Gossamer Bio (GOSS) stake by 76% in Q2 2026, buying an estimated $56K and bringing the position to 463,708 shares worth $76K. The position accounts for ﹤0.01% of the portfolio, ranked #1153.

Virtu Financial first reported a position in GOSS in Q2 2020 and has held it in 8 quarters since. The position peaked at $186K in Q3 2022. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

Virtu Financial held 463,708 shares of Gossamer Bio worth $76K as of Q2 2026.
Virtu Financial bought 200,496 Gossamer Bio shares in Q2 2026, an estimated $56K.
Gossamer Bio made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1153 holding.
Virtu Financial first reported a position in Gossamer Bio in Q2 2020 and has held it in 8 quarters since.
Virtu Financial's Gossamer Bio position peaked at $186K in Q3 2022.
170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.